Blackstone Life Sciences Advisors (BXLS Advisors) provides investment advice to its life science investment funds. These funds focus on financing late-stage clinical products, pre-approval royalties, and other life science investments. BXLS Advisors makes investment decisions for the funds, but not for individual investors in those funds. The firm also provides portfolio management services to affiliated private investment funds.
BXLS Advisors does not directly manage investments for individual investors. It manages investment funds for institutions and high net worth individuals. The fees are determined through negotiations with investors in each fund.